CHUSX Performance — Alger Global Equity Fund, Class A
Data updated: 2026-09-25
CHUSX returned +5.28% year to date and +4.61% over one year to Jul 2026. Annualised returns are +10.28% over 3 years and +5.76% over 5 years. The fund trailed its Global Large Growth category average: $100 invested three years ago grew to $134, against $152 for the category, and to $105 over one year, against $113. Volatility over the past three years was 13.29% a year. In the 12 months to Jul 2026 the fund lost a net $1.5M, and assets reached $19.77M.
CHUSX Growth of $100
What $100 invested in Alger Global Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Large Growth category average over the same months.
| Period | CHUSX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $105 | $113 |
| 3 years (Aug 2023 – Jul 2026) | $134 | $152 |
| 5 years (Aug 2021 – Jul 2026) | $132 | $139 |
| Since data start (Aug 2019 – Jul 2026) | $131 | $214 |
CHUSX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.28% |
| 1 year | +4.61% |
| 3 years (annualised) | +10.28% |
| 5 years (annualised) | +5.76% |
CHUSX Annual Returns
Calendar-year total returns of Alger Global Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +5.28% |
| 2025 | +7.91% |
| 2024 | +18.32% |
| 2023 | −0.40% |
| 2022 | −0.95% |
| 2021 | −0.50% |
| 2020 | −0.29% |
| 2019 (Aug–Dec) | −0.19% |
CHUSX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.4% | −0.3% | −6.8% | +9.6% | +3.5% | +0.1% | −4.3% | — | — | — | — | — |
| 2025 | +2.3% | −3.2% | −7.2% | +3.8% | +7.0% | +6.0% | +0.4% | +0.5% | +1.5% | +0.9% | −3.2% | −0.4% |
| 2024 | +0.3% | +7.0% | +3.5% | −5.1% | +4.5% | +2.4% | +0.2% | +3.0% | +0.5% | −0.4% | +5.9% | −4.0% |
| 2023 | +0.1% | −0.1% | 0.0% | −0.1% | −0.1% | 0.0% | 0.0% | −0.1% | −0.1% | −0.1% | +0.1% | 0.0% |
| 2022 | −0.2% | −0.1% | 0.0% | −0.2% | −0.1% | −0.1% | 0.0% | −0.1% | −0.2% | 0.0% | 0.0% | −0.1% |
| 2021 | −0.1% | −0.1% | −0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | −0.1% | 0.0% | −0.1% | −0.1% |
| 2020 | −0.1% | −0.1% | −0.2% | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% | −0.1% | −0.1% | +0.1% | 0.0% |
| 2019 | — | — | — | — | — | — | — | −0.1% | −0.1% | 0.0% | 0.0% | 0.0% |
CHUSX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 13.29%
- 3-year Sharpe ratio: 0.44 (vs 4.5% risk-free rate)
- Best month: +9.59% (Apr 2026)
- Worst month: −7.24% (Mar 2025)
CHUSX Fund Flows
Monthly money in and out of Alger Global Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$1.5M
- 12-month gross sales (incl. reinvestments): $2.3M
- Sales ÷ redemptions: 0.62×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $37K | $115K | −$78K |
| Jun 2026 | $31K | $165K | −$134K |
| May 2026 | $7K | $264K | −$256K |
| Apr 2026 | $131K | $157K | −$26K |
| Mar 2026 | $182K | $211K | −$29K |
| Feb 2026 | $5K | $37K | −$32K |
| Jan 2026 | $49K | $1.2M | −$1.2M |
| Dec 2025 | $1.6M | $368K | $1.3M |
| Nov 2025 | $163K | $588K | −$425K |
| Oct 2025 | $5K | $185K | −$180K |
| Sep 2025 | $41K | $222K | −$181K |
| Aug 2025 | $57K | $294K | −$237K |
CHUSX Assets Under Management
Net assets of Alger Global Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $19.77M |
| 2026-04-30 | $20.41M |
| 2026-01-30 | $20.14M |
| 2025-10-31 | $22.04M |
| 2025-07-31 | $21.98M |
| 2025-04-30 | $19.91M |
| 2025-01-31 | $21.64M |
| 2024-10-31 | $21.60M |
| 2024-07-31 | $21.10M |
| 2024-04-30 | $20.09M |
| 2024-01-31 | $19.65M |
| 2023-10-31 | $16.99M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.